Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady ...

As a sales rep for drug manufacturers Questcor, Lisa Pratta always suspected the company’s business practices weren’t just ...

The payments have raised concerns that doctors could be influenced to favour specific drugs or prescribe them over talking ...

Trans-Tasman drug developer Aft Pharmaceuticals is targeting lucrative niche diseases its Big Pharma rivals have ignored ...

An Enquirer analysis found that doctors, nurses and other practitioners received $136 million from pharma and biotech ...

The Make America Healthy Again Commission that Robert F. Kennedy Jr. leads will release a strategy to combat chronic disease ...

Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

Tariffs on pharmaceutical imports could hurt Lilly, especially with its dependence on products made in Ireland. The president ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

Novo Nordisk has filed a lawsuit in Delhi High Court. The suit aims to stop Dr Reddy's Laboratories and OneSource from ...

Enquirer analysis of industry payments to Cincinnati practitioners found that companies spent $136 million ... doctors have received money from Big Pharma, Doyle was curious about what she ...